3-sulfa emätinpuikko
neofarma - urea, sulfabenzamide, sulfacetamide, sulfathiazole - emätinpuikko - sulfonamidiyhdistelmävalmisteet
galvus
novartis europharm limited - vildagliptiini - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptiini - diabetes mellitus, tyyppi 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).
xiliarx
novartis europharm limited - vildagliptiini - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 käytettävissä olevista tiedoista eri yhdistelmistä).
salmeson 50 mikrog / 250 mikrog / annos inhalaatiojauhe, annosteltu
elpen pharmaceutical co. inc. - salmeterol xinafoate, fluticasone propionate - inhalaatiojauhe, annosteltu - 50 mikrog / 250 mikrog / annos - salmeteroli ja flutikasoni
salmeson 50 mikrog / 500 mikrog / annos inhalaatiojauhe, annosteltu
elpen pharmaceutical co. inc. - salmeterol xinafoate, fluticasone propionate - inhalaatiojauhe, annosteltu - 50 mikrog / 500 mikrog / annos - salmeteroli ja flutikasoni
joflupaani (123i) rotop 74 mbq/ml injektioneste, liuos
rotop radiopharmacy gmbh - ioflupane - injektioneste, liuos - 74 mbq/ml - jodi(123i)joflupaani